|
Mr. Schmidt brings to Chelsea over 25 years of experience and a proven track record in domestic and international pharmaceutical sales and strategic marketing for launching industry leading drugs including Pegasys , Naprosyn , Anaprox , Cialis , Cymbalta , and Strattera. Over the course of his career, Mr. Schmidt has worked for companies such as Hoffmann La Roche and Syntex Laboratories and served as the Vice President assigned to Eli Lilly marketing for Thomson Advanced Therapeutics Communications. During his tenure at Hoffmann-La Roche, Mr. Schmidt served as International Business Leader responsible for global pre-launch marketing preparation, launch market plans, and life cycle planning for Pegasys in Hepatitis. Prior to joining Roche, Mr. Schmidt served in a number of progressively senior positions at Syntex Laboratories variously directing New Product Development, Sales Force Strategies, OBYN Sales, and Sales Training. Mr. Schmidt has a BS in Experimental Psychology and an MBA in International Marketing from the University of San Francisco. | 